HK167295A - Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens - Google Patents

Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens Download PDF

Info

Publication number
HK167295A
HK167295A HK167295A HK167295A HK167295A HK 167295 A HK167295 A HK 167295A HK 167295 A HK167295 A HK 167295A HK 167295 A HK167295 A HK 167295A HK 167295 A HK167295 A HK 167295A
Authority
HK
Hong Kong
Prior art keywords
glycoprotein
hiv
cells
retrovirus
glycoproteins
Prior art date
Application number
HK167295A
Other languages
German (de)
English (en)
French (fr)
Inventor
Montagnier Luc
Hovanessian Ara
Laurent Anne
Krust Bernard
Rey Marie-Anne
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8807817A external-priority patent/FR2632644B1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of HK167295A publication Critical patent/HK167295A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
HK167295A 1988-06-09 1995-10-26 Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens HK167295A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20434688A 1988-06-09 1988-06-09
FR8807817A FR2632644B1 (fr) 1988-06-10 1988-06-10 Antigenes precurseurs des glycoproteines d'enveloppe d'un retrovirus humain hiv-2 et antigenes presentant une parente immunologique avec ces derniers. preparation de ces antigenes. application au diagnostic

Publications (1)

Publication Number Publication Date
HK167295A true HK167295A (en) 1995-11-03

Family

ID=26226719

Family Applications (1)

Application Number Title Priority Date Filing Date
HK167295A HK167295A (en) 1988-06-09 1995-10-26 Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens

Country Status (9)

Country Link
EP (1) EP0354072B1 (es)
JP (1) JP3093763B2 (es)
AT (1) ATE122236T1 (es)
CA (1) CA1341488C (es)
DE (1) DE68922540T2 (es)
DK (1) DK175668B1 (es)
ES (1) ES2074085T3 (es)
HK (1) HK167295A (es)
PT (1) PT90800B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005078443A1 (en) * 2004-02-13 2005-08-25 Inverness Medical Switzerland Gmbh Determination of infection by the immune response to a carbohydrate moiety

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0269520A3 (fr) * 1986-11-21 1988-08-24 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
ES2104556T3 (es) * 1987-01-16 1997-10-16 Pasteur Institut Peptidos que tienen propiedades inmunologicas de hiv-2.

Also Published As

Publication number Publication date
DE68922540T2 (de) 1995-10-05
EP0354072A1 (fr) 1990-02-07
JP3093763B2 (ja) 2000-10-03
EP0354072B1 (fr) 1995-05-10
DK284389D0 (da) 1989-06-09
DE68922540D1 (de) 1995-06-14
ES2074085T3 (es) 1995-09-01
ATE122236T1 (de) 1995-05-15
CA1341488C (fr) 2005-08-30
PT90800A (pt) 1989-12-29
PT90800B (pt) 1994-11-30
DK284389A (da) 1989-12-10
JPH02119791A (ja) 1990-05-07
DK175668B1 (da) 2005-01-10

Similar Documents

Publication Publication Date Title
Bernstein et al. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides
Tsai et al. Inhibition of human immunodeficiency virus infectivity by chloroquine
Krangel et al. Assembly and maturation of HLA-A and HLA-B antigens in vivo
Robinson JR et al. Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis
US5807992A (en) HIV-2 transmembrane glycoprotein homodimer (gp 80)
Edson et al. Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus
Taylor et al. Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cells
IE872219L (en) Treatment of hiv infections
EP0542998A1 (en) Vaccine and treatment method of human immunodeficiency virus infection
US5312902A (en) Dimer of the precursor of HIV-2 envelope glycoprotein
US7507417B2 (en) Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparation
Bahraoui et al. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans
WO1998009981A9 (en) Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity
WO1998009981A1 (en) Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity
JP3093763B2 (ja) ヒトレトロウィルスｈｉｖ―２の外被糖タンパク質の前駆抗原及びそれと免疫学的同族性をもつ抗原、ならびにこれらの抗原の調製方法及び診断への応用
US6056963A (en) Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins
JP2008156350A (ja) Ｈｉｖ−２型ヒトレトロウイルスのトランスメンブランエンベロープ糖タンパク質の抗原、及び、該抗原に免疫類似性を有する抗原
FR2632526A1 (fr) Composition pharmaceutique active sur les residus glucose de la glycoproteine gp 150
Kaluza et al. The significance of carbohydrate trimming for the antigenicity of the Semliki Forest virus glycoprotein E2
FR2632644A1 (fr) Antigenes precurseurs des glycoproteines d'enveloppe d'un retrovirus humain hiv-2 et antigenes presentant une parente immunologique avec ces derniers. preparation de ces antigenes. application au diagnostic
EP0400245B1 (en) Proteins and glycoproteins of the HIV-2 EHO retrovirus antibodies directed against them - application for the diagnosis
Jacob et al. Aminosugar attenuation of HIV infection
EP0379295A2 (en) Anti-tryptase antibody and composition for treatment of AIDS using the same
LV10492B (en) Vaccine and treatment method for human immunodeficiency virus
Spiro et al. The mechanism of action of iminosugars as antiretrovirals

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090608